Malignant Skin Tumor Misdiagnosed as a Benign Skin Lesion

  • Hwang, So-Min (Aesthetic, Plastic and Reconstructive Surgery Center) ;
  • Pan, Hao-Ching (Aesthetic, Plastic and Reconstructive Surgery Center) ;
  • Hwang, Min-Kyu (Aesthetic, Plastic and Reconstructive Surgery Center) ;
  • Kim, Min-Wook (Aesthetic, Plastic and Reconstructive Surgery Center) ;
  • Lee, Jong-Seo (Aesthetic, Plastic and Reconstructive Surgery Center)
  • Received : 2016.01.11
  • Accepted : 2016.04.16
  • Published : 2016.06.20


Despite the fact that benign skin lesions can undergo malignant transformation, the necessity and timing of the surgical resection have yet to be established. In this study, we analyse three cases of benign-appearing skin lesions, which were found to be carcinomatous on histologic examination and review the literature regarding the importance of prophylactic removal of benign-appearing skin lesion. The first and second cases were female patients wishing for cosmetic surgery. The first patient had a benign-appearing lesion on dorsum nasi, and the second patient had an inconspicuous lesion right along the right nasolabial fold. The third patient was a middle-aged male with a pigmented lesion on the left cheek, who presented to the clinic only after having met the operating surgeon through an acquaintance outside the hospital setting. All of the lesions were suspected to be of benign nature and were excised for cosmesis only. However, histologic examination of these lesions showed that the first two tumors were basal cell carcinoma with the last tumor being squamouse cell carcinoma. Thus, it is considered that removal of benign like skin lesion will result in good prognosis of patients scheduled to undergo other surgery.


  1. Dilek N, Bedir R, Yuksel D, Ataseven A. A case of basal cell carcinoma secondary to nevus sebaceous. Int J Case Rep Imag 2014;5:277-80.
  2. Enei ML, Paschoal FM, Valdes G, Valdes R. Basal cell carcinoma appearing in a facial nevus sebaceous of Jadassohn: dermoscopic features. An Bras Dermatol 2012;87:640-2.
  3. Rosen H, Schmidt B, Lam HP, Meara JG, Labow BI. Management of nevus sebaceous and the risk of Basal cell carcinoma: an 18-year review. Pediatr Dermatol 2009;26:676-81.
  4. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681-90.
  5. Linden KG. Screening and early detection of skin cancer. Curr Oncol Rep 2004;6:491-6.
  6. U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:188-93.
  7. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146 Suppl 61:1-6.
  8. Wiznia LE, Shanley KM, Federman DG. Advanced, neglected basal cell carcinoma. South Med J 2014;107:242-5.
  9. Karynne OD, John KG, David JL. Epithelial precancerous lesions. In: Fitzpatrick TB, Goldsmith LA, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGrawHill; 2012. p.1261-90.
  10. Ogawa R. Benign and malignant nonmelanocytic tumors of the skin and do Tissue. In: Neligan PC, Gurtner GC, editors. Plastic Surgery. 3rd ed. Seattle: Elsevier; 2013. p.717-42.
  11. Telfer NR, Colver GB, Morton CA; British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35-48.
  12. Heal CF, Raasch BA, Buettner PG, Weedon D. Accuracy of clinical diagnosis of skin lesions. Br J Dermatol 2008;159:661-8.